CANCER

CANCER Journal

publication venue for

Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancer. 130:1940-1951. 2024
Outcomes of adjuvant radiation therapy after chemotherapy in resected extrahepatic cholangiocarcinoma: A National Cancer Database analysis. 129:890-900. 2022
Variation in outcomes across surgeons meeting the Leapfrog volume standard for complex oncologic surgery. 127:4059-4071. 2021
Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer. 127:2279-2293. 2021
Nab-paclitaxel in older patients with non-small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy. 126:1060-1067. 2020
Association between depth of response and survival in patients with advanced-stage non-small cell lung cancer treated with first-line chemotherapy. 125:2394-2399. 2019
Effect of an equal-access military health system on racial disparities in colorectal cancer screening. 124:3724-3732. 2018
Comparison of Unilateral Versus Bilateral Intensity-Modulated Radiotherapy for Surgically Treated Squamous Cell Carcinoma of the Palatine Tonsil. 123:4594-4607. 2017
Phase 1/2 Study of Rilotumumab (AMG 102), a Hepatocyte Growth Factor Inhibitor, and Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer. 123:2936-2944. 2017
The Role of Postoperative Chemoradiation for Oropharyngeal Carcinoma: A Critical Appraisal Revisited 2017
Poor Compliance With Adjuvant Chemotherapy Use Associated With Poorer Survival in Patients With Rectal Cancer: An NCDB Analysis. 123:52-61. 2017
Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases. 121:3836-3843. 2015
Patterns of change in cognitive function with anastrozole therapy. 121:2627-2636. 2015
The role of postoperative chemoradiation for oropharynx carcinoma: A critical appraisal of the published literature and National Comprehensive Cancer Network guidelines 2015
Clinicopathologic Features and Outcomes of Patients With Lung Adenocarcinomas Harboring BRAF Mutations in the Lung Cancer Mutation Consortium. 121:448-456. 2015
Eliminating Radiotherapy to the Contralateral Retropharyngeal and High Level II Lymph Nodes in Head and Neck Squamous Cell Carcinoma Is Safe and Improves Quality of Life. 120:3994-4002. 2014
Patterns of Presentation and Failure in Patients With Gliomatosis Cerebri Treated With Partial-Brain Radiation Therapy. 120:2713-2720. 2014
Adjuvant radiotherapy and lymph node dissection in pancreatic cancer treated with surgery and chemotherapy. 120:1171-1177. 2014
The prognostic and predictive value of KRAS oncogene substitutions in lung adenocarcinoma. 119:2268-2274. 2013
Increased Survival Associated With Surgery and Radiation Therapy in Metastatic Gastric Cancer A Surveillance, Epidemiology, and End Results Database Analysis. 119:1636-1642. 2013
Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. 118:3519-3530. 2012
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. 118:3283-3293. 2012
Predicting the need for palliative thoracic radiation after first-line chemotherapy for advanced nonsmall cell lung carcinoma. 118:2744-2751. 2012
Improved Survival in Patients With Lymph Node-Positive Gastric Cancer Who Received Preoperative Radiation An Analysis of the Surveillance, Epidemiology, and End Results Database. 117:3908-3916. 2011
Early Findings on Toxicity of Proton Beam Therapy With Concurrent Chemotherapy for Nonsmall Cell Lung Cancer. 117:3004-3013. 2011
Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With Acute Myeloid Leukemia. 116:3001-3005. 2010
Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma. 113:1309-1314. 2008
ProApoliploprotein A1 - A serum marker of brain metastases in lung cancer patient. 112:1313-1324. 2008
Phase II study of lenalidomide in patients with metastatic renal cell carcinoma. 107:2609-2616. 2006
Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma. 104:1478-1486. 2005
S100 beta as a predictor of brain metastases - Brain versus cerebrovascular damage. 104:817-824. 2005
Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias - A retrospective review. 101:790-795. 2004
Measuring the side effects of taxane therapy in oncology - The functional assessment of cancer therapy-taxane (FACT-taxane). 98:822-831. 2003
The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel. 98:779-788. 2003
Phase I trial of weekly docetaxel and gemcitabine in patients with refractory malignancies. 97:170-178. 2003
Phase II trial of irinotecan, paclitaxel and carboplatin in patients with previously untreated stage IIIB/IV nonsmall cell lung carcinoma. 95:1520-1527. 2002
Second-line, low-dose, weekly paclitaxel in patients with Stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel. 95:1265-1273. 2002
Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable Stage IIIA/B nonsmall cell lung carcinoma - A modified Phase I/II trial. 92:1213-1223. 2001
Enteral nutrition during the treatment of head and neck carcinoma - Is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?. 91:1785-1790. 2001
Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma - A modified phase I trial. 89:534-542. 2000
Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma - Pathologic and prognostic correlations. 82:1495-1500. 1998
Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy. 78:1693-1700. 1996
FREQUENT LOSS OF HETEROZYGOSITY FOR RB, TP53, AND CHROMOSOME ARM 3P, BUT NOT NME1 IN SQUAMOUS-CELL CARCINOMAS OF THE SUPRAGLOTTIC LARYNX. 73:2472-2480. 1994
CARDIAC SYNOVIAL SARCOMA WITH TRANSLOCATION (X 18) ASSOCIATED WITH ASBESTOS EXPOSURE. 73:74-78. 1994
EXTRANEURAL METASTASES OF INFRATENTORIAL GLIOBLASTOMA-MULTIFORME TO THE PERITONEAL-CAVITY. 69:2149-2153. 1992
TOTAL GASTRECTOMY FOR ADVANCED CANCER - A WORTHWHILE PALLIATIVE PROCEDURE. 68:1863-1868. 1991
TURCOTS-SYNDROME - FLOW CYTOMETRIC ANALYSIS. 68:1633-1639. 1991
PRIMARY LYMPHOMA OF THE LIVER - 10 CASES AND A REVIEW OF THE LITERATURE 1985

category

ONCOLOGY Web of Science Category

International Standard Serial Number (ISSN)

0008-543X

Electronic International Standard Serial Number (EISSN)

1097-0142

journal abbreviation

CANCER
CANCER-AM CANCER SOC